Simcere Pharmaceutical Group Limited Share Price
Stocks
2096
HK0000658531
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.61 HKD | -3.96% |
|
+6.06% | +5.35% |
| 07-09 | Simcere Pharma's Acute Ischemic Stroke Included in National Essential Medicines List | MT |
| 06-15 | Simcere Pharma Gets China Nod for Tumor Drug Trial | MT |
| Market Cap | 4.13B 32.38B 3.61B 3.33B 3.07B 5.79B 398B 5.92B 39.81B 15.66B 195B 15.51B 15.17B 671B | P/E 2026 * |
16.7x | P/E 2027 * | 14.1x |
|---|---|---|---|---|---|
| Enterprise Value | 3.91B 30.66B 3.42B 3.15B 2.91B 5.48B 377B 5.6B 37.69B 14.82B 184B 14.68B 14.36B 635B | EV / Sales 2026 * |
2.66x | EV / Sales 2027 * | 2.43x |
| Free-Float |
32.48% | Yield 2026 * |
3.04% | Yield 2027 * | 3.99% |
| 1 day | -3.96% | ||
| 1 week | +6.06% | ||
| Current month | +28.02% | ||
| 1 month | +26.86% | ||
| 3 months | -8.95% | ||
| 6 months | +8.33% | ||
| Current year | +5.35% |
| 1 week | 12.02 |  | 13.4 |
| 1 month | 9.07 | | 13.4 |
| Current year | 9.07 | | 14.28 |
| 1 year | 9.07 | | 15.08 |
| 3 years | 4.94 | | 15.08 |
| 5 years | 4.94 | | 15.08 |
| 10 years | 4.94 | | 15.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yun Shu Zhou
CEO | Chief Executive Officer | 54 | 24/03/2026 |
Yushan Wan
DFI | Director of Finance/CFO | 55 | 18/11/2019 |
Goh Han
CTO | Chief Tech/Sci/R&D Officer | 51 | 30/11/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CHM | Chairman | 63 | 07/10/2012 |
Yushan Wan
BRD | Director/Board Member | 55 | 18/11/2019 |
Ren Hong Tang
BRD | Director/Board Member | 46 | 31/10/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 08/07/26 | Other | Director | -100,000 | 0.0039% | ||
| 08/07/26 | Other | Founder | -100,000 | 0.0039% | ||
| 06/07/26 | Other | Founder | -100,000 | 0.0039% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.96% | +6.06% | +15.69% | +66.36% | 4.3B | |
| -0.90% | -0.31% | +13.62% | +80.12% | 48.56B | |
| -0.23% | -0.63% | +67.00% | +115.81% | 35.65B | |
| -0.76% | -1.57% | -3.87% | +37.62% | 11.98B | |
| -0.88% | -1.32% | +18.04% | +92.11% | 11.95B | |
| +1.12% | +1.90% | +34.67% | +129.06% | 9.29B | |
| -0.75% | -0.91% | +18.26% | +37.23% | 6.95B | |
| +3.37% | -0.96% | +46.11% | -4.38% | 6.79B | |
| -2.25% | -1.40% | +1.39% | +218.40% | 6.7B | |
| -9.93% | +5.82% | -22.89% | +16.29% | 6.81B | |
| Average | -1.52% | +1.55% | +18.80% | +78.86% | 14.9B | |
| Weighted average by Cap. | -0.96% | +0.62% | +26.19% | +86.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.47B 11.54B 1.29B 1.19B 1.09B 2.06B 142B 2.11B 14.19B 5.58B 69.45B 5.53B 5.41B 239B | 1.67B 13.07B 1.46B 1.34B 1.24B 2.33B 160B 2.39B 16.06B 6.32B 78.6B 6.26B 6.12B 271B |
| Net income | 241M 1.89B 211M 194M 179M 338M 23.2B 345M 2.32B 913M 11.36B 905M 885M 39.12B | 283M 2.22B 247M 228M 210M 396M 27.24B 405M 2.73B 1.07B 13.34B 1.06B 1.04B 45.93B |
| Net Debt | -221M -1.73B -193M -178M -164M -309M -21.24B -316M -2.13B -836M -10.4B -828M -810M -35.81B | -84.71M -664M -74.03M -68.31M -62.96M -119M -8.16B -121M -816M -321M -4B -318M -311M -13.75B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | HK$12.61 | -3.96% | 11,227,000 |
| 16/07/26 | HK$13.13 | +1.08% | 7,506,502 |
| 15/07/26 | HK$12.99 | +3.59% | 14,655,750 |
| 14/07/26 | HK$12.54 | +0.64% | 7,181,127 |
| 13/07/26 | HK$12.46 | +3.06% | 13,496,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 2096 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
